Gideon Capital Advisors’s Gilead Sciences GILD Stock Holding History

Gideon Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,282	Closed	-$603K	–	332
2019 Q1	$603K	Sell	9,282 -3,866	-29%	-$257K	0.22%	129
2018 Q4	$822K	Buy	13,148 +10,420	+382%	+$728K	0.34%	86
2018 Q3	$211K	Buy	+2,728	New	+$206K	0.1%	310
2017 Q4	–	Sell	-5,785	Closed	-$469K	–	334
2017 Q3	$469K	Buy	5,785 +534	+10%	+$40.8K	0.46%	53
2017 Q2	$372K	Buy	5,251 +330	+7%	+$22K	0.41%	94
2017 Q1	$334K	Sell	4,921 -6,001	-55%	-$422K	0.2%	209
2016 Q4	$783K	Buy	+10,922	New	+$812K	0.5%	19
2015 Q4	–	Sell	-3,175	Closed	-$312K	–	228
2015 Q3	$312K	Buy	+3,175	New	+$353K	0.18%	162
2014 Q4	–	Sell	-21,930	Closed	-$2.33M	–	240
2014 Q3	$2.33M	Buy	+21,930	New	+$2.15M	0.9%	25
2014 Q2	–	Sell	-14,847	Closed	-$1.05M	–	271
2014 Q1	$1.05M	Buy	+14,847	New	+$1.16M	0.58%	55

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Gideon Capital Advisors's GILD Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 9,282 shares — an estimated $603K sold.

Gideon Capital Advisors first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $2.33M in Q3 2014. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

Gideon Capital Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
Gideon Capital Advisors sold 9,282 Gilead Sciences shares in Q2 2019, an estimated $603K.
Gideon Capital Advisors first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Gideon Capital Advisors's Gilead Sciences position peaked at $2.33M in Q3 2014.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.